Pancreatic Cancer Caught Early Because of My Vigilance
Beverly Leighton joined a screening study and underwent genetic testing because of her family history of pancreatic cancer.
Genetic Testing Leads Me to a PARP Inhibitor Trial
Harvey Parker had genetic testing as part of his initial pancreatic cancer treatment. The BRCA2 mutation led him to a PARP inhibitor clinical trial when the cancer returned.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligable to try a new drug.
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother
When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve became vigilant about the disease, which lead to his early diagnosis.
Facing Pancreatic Cancer and Making the Most of Borrowed Time
With a young family, Justin Baker is very glad to have more time than anticipated as he faces stage IV pancreatic cancer.
Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life
When standard treatment did not work for Roy Vinke's pancreatic cancer, he had genomic profiling done. A mutation was found, changing his treatment plan.
Choosing the Strongest Chemotherapy for Pancreatic Cancer
Miriam Hermosa decided to take advantage of her relatively good health and try pancreatic cancer treatment with FOLFIRINOX to get more time with her family.
A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
Aiming to be More than a Statistic
Dr. Paul Silverstein knew that he needed genomic testing, immunotherapy, and a clinical trial in his battle with pancreatic cancer.
Genomic Testing of Pancreatic Tumor Leads to an Important Discovery
Connie Waxman learned the value of palliative care after chemotherapy, radiation, and a pancreatectomy for pancreatic cancer; then she had genomic testing.
